MedPath

Clinical outcomes and cost-effectiveness of a diagnostic and treatment strategy of upfront CTCA plus selective non-invasive functional imaging compared with standard care in patients with chest pain and suspected coronary artery disease

Recruiting
Conditions
chest pain
coronary artery disease
10011082
Registration Number
NL-OMON56132
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
6444
Inclusion Criteria

Outpatient presentation to the cardiologist with chest pain with suspected CAD
- >18 years old

Exclusion Criteria

Patients who meet any of the following criteria will be excluded from
participation:
- Presentation with acute coronary syndrome (NSTEMI/STEMI/unstable angina)
- Acute coronary syndrome (including unstable angina) within past 3 months
- History of obstructive coronary artery disease on imaging (>50% DS)
- History of PCI and / or CABG
- Severe renal failure (eGFR <30 ml/min)
- Severe allergy to iodinated contrast medium
- Known pregnancy
- Patients with an estimated life expectancy of less than 1 year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Occurrence of MACE defined as mortality or non-fatal myocardial infarction<br /><br>2. Costs per quality adjusted life year (QALY)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Please see page 10 of the research protocol (Chapter 2.2: Secondary objectives) </p><br>
© Copyright 2025. All Rights Reserved by MedPath